Skip to content
Menu

Chemomab Therapeutics Ltd. CMMB

Full chart Compare
Set alert

Price alert · CMMB

All alert types
1.19 USD +0.05 (+4.39%)

Regular-session close

1.19 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

1.15 Day range 1.33
1.00 52-week range 2.83
YTD
-27.88%
1 year
-51.03%

Ownership

  • Institutions 28.0%
  • Insiders 11.3%
  • Public and other holders 60.7%
Held by insiders 11.29%
Held by institutions 27.99%
Float held by institutions 31.55%
Institutions 17

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Orbimed Advisors LLC.9.23%1,741,2732.87MSep 29, 2024
Sphera Funds Management Ltd.6.44%1,214,5752.00MSep 29, 2024
Yelin Lapidot Holdings Management Ltd.4.29%809,7171.34MSep 29, 2024
Morgan Stanley2.13%402,272663.75KSep 29, 2024
Ikarian Capital, LLC1.13%213,392352.10KSep 29, 2024
Two Sigma Securities, LLC0.21%39,93965.90KSep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Blackstone Alternative Multi-Strategy Fund0.00%200329Jun 29, 2024

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

CMMB insiders
InsiderRelationLatest transactionDateShares held
MOR GEORGE ADIOfficer and DirectorSaleJan 2, 20230
ORBIMED ISRAEL GP LTD.Beneficial Owner of more than 10% of a Class of SecuritySaleJan 2, 20230